United Kingdom Neovascular AMD Database study: Time to reactivation after a pause in treatment - outcomes from 92,000 intravitreal ranibizumab injections

被引：0
|
作者：
Keane, Pearse Andrew [1 ]
McKibbin, Martin [2 ]
Lee, Aaron Y. [1 ]
Chakravarthy, Usha [3 ]
Johnston, Robert [4 ]
Egan, Catherine A. [1 ]
Sim, Dawn A. [1 ]
Zarranz-Ventura, Javier [5 ]
Tufail, Adnan [1 ]
机构：
[1] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Opht, London, England
[2] St James Univ Hosp, Ophthalmol, Leeds, W Yorkshire, England
[3] Queens Univ, Ctr Vasc & Vis Sci, Belfast, Antrim, North Ireland
[4] Cheltenham Gen Hosp, Retinal Serv, Cheltenham, Glos, England
[5] Bristol Eye Hosp, Retina Serv, Bristol, Avon, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 462 clinical (human) or epidemiologic studies: outcomes/complications; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3066
引用
收藏
页数：2
相关论文
共 11 条
  • [1] United Kingdom Neovascular AMD Database study: outcomes of over 92,000 intravitreal ranibizumab injections
    Tufail, Adnan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections
    Madhusudhana, Krishnappa C.
    Lee, Aaron Y.
    Keane, Pearse A.
    Chakravarthy, Usha
    Johnston, Robert L.
    Egan, Catherine A.
    Sim, Dawn
    Zarranz-Ventura, Javier
    Tufail, Adnan
    McKibbin, Martin
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (12) : 1617 - 1622
  • [3] Real-life neovascular AMD treatment considering reimbursement in Turkiye: One-year comparison of switching to intravitreal ranibizumab or aflibercept after treatment failure with three loading intravitreal bevacizumab injections
    Sevik, Mehmet Orkun
    Tiras, Nimet Zeynep
    Aykut, Aslan
    Yigit, Didem Dizdar
    Sahin, Ozlem
    NORTHERN CLINICS OF ISTANBUL, 2024, 11 (05) : 451 - 459
  • [4] Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration
    Kent, Jerrod S.
    Iordanous, Yiannis
    Mao, Alex
    Powell, Anne-Marie
    Kent, Shefalee Shukla
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2012, 47 (02): : 159 - 164
  • [5] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [6] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
  • [7] Impact of Delayed Time to Treatment on Visual Outcomes in Neovascular AMD: Data From the HARBOR Study
    Goldberg, Roger A.
    Hill, Lauren F.
    Davis, Tatiana
    Quezada Ruiz, Carlos
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (02): : 62 - +
  • [8] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [9] Treatment of Type 2 Diabetes and Outcomes in Patients with Heart Failure: A Nested Case Control Study from the United Kingdom General Practice Research Database
    Eurich, Dean T.
    MacDonald, Michael R.
    Majumdar, Sumit R.
    Lewsey, James D.
    Bhagra, Sai
    Jhund, Pardeep S.
    Petrie, Mark C.
    McMurray, John J. V.
    McAlister, Finlay A.
    DIABETES, 2010, 59 : A199 - A199
  • [10] Evaluation of time-to-recurrence of disease activity in treatment-naive patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study
    Quaranta, Maddalena
    Devin, Francois
    Quentel, Gabriel
    Uzzan, Joel
    Fourmaux, Eric
    Castelnovo, Laurent
    Roquet, Wilfried
    Francais-Maury, Catherine
    Razavi, Sam
    San Nicolas, Nathalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12